Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 18, 2019
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients
Giorgio Scagliotti, Denis Moro-Sibilot, Jens Kollmeier, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 13, 2019
Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial
Dirk-Jan Slebos, Pallav L Shah, Felix J F Herth, et al.
Respiration; International Review of Thoracic Diseases
|
May 9, 2021
Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema
Karin Klooster, Arschang Valipour, Charles-Hugo Marquette, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
November 12, 2020
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
Arschang Valipour, Pallav L Shah, Felix J Herth, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 13, 2021
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada
Didier Debieuvre, Rosalyn A Juergens, Bernard Asselain, et al.
The Lancet. Oncology
|
February 22, 2015
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
Luis Paz-Ares, Jörg Mezger, Tudor E Ciuleanu, et al.
Nature Communications
|
March 20, 2021
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Lukas Wettstein, Tatjana Weil, Carina Conzelmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
Jan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Clinical & Experimental Metastasis
|
July 23, 2025
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)
Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 12, 2023
Early Detection of Lung Cancer Using Small RNAs
Tobias Sikosek, Rastislav Horos, Franziska Trudzinski, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 18, 2019
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients
Giorgio Scagliotti, Denis Moro-Sibilot, Jens Kollmeier, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 13, 2019
Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial
Dirk-Jan Slebos, Pallav L Shah, Felix J F Herth, et al.
Respiration; International Review of Thoracic Diseases
|
May 9, 2021
Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema
Karin Klooster, Arschang Valipour, Charles-Hugo Marquette, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
November 12, 2020
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
Arschang Valipour, Pallav L Shah, Felix J Herth, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 13, 2021
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada
Didier Debieuvre, Rosalyn A Juergens, Bernard Asselain, et al.
The Lancet. Oncology
|
February 22, 2015
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
Luis Paz-Ares, Jörg Mezger, Tudor E Ciuleanu, et al.
Nature Communications
|
March 20, 2021
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Lukas Wettstein, Tatjana Weil, Carina Conzelmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2024
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
Jan A Stratmann, Friederike C Althoff, Paula Doebel, et al.
Clinical & Experimental Metastasis
|
July 23, 2025
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)
Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 12, 2023
Early Detection of Lung Cancer Using Small RNAs
Tobias Sikosek, Rastislav Horos, Franziska Trudzinski, et al.
Page
of 11